X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Strides Arcolab with ASTRAZENECA PHARMA - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STRIDES SHASUN LTD vs ASTRAZENECA PHARMA - Comparison Results

STRIDES SHASUN LTD    Change

Strides Arcolab is an Indian pharmaceutical company headquartered at Bangalore. The company is primarily involved in two businesses notably the pharma business and the specialized sterile products business branded as Agila. This segment focuses large... More

ASTRAZENECA PHARMA 
   Change

AstraZeneca Pharma India Limited (APIL) is a 90% subsidiary of the UK based AstraZeneca Pharmaceuticals, which is one of the world's leading pharma companies. APIL has interests in the six crucial areas of cardiovascular, respiratory, maternal health... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STRIDES SHASUN LTD ASTRAZENECA PHARMA STRIDES SHASUN LTD/
ASTRAZENECA PHARMA
 
P/E (TTM) x 14.0 90.3 15.5% View Chart
P/BV x 1.9 12.9 14.7% View Chart
Dividend Yield % 0.6 0.0 -  

Financials

 STRIDES SHASUN LTD   ASTRAZENECA PHARMA
EQUITY SHARE DATA
    STRIDES SHASUN LTD
Mar-16
ASTRAZENECA PHARMA
Mar-14
STRIDES SHASUN LTD/
ASTRAZENECA PHARMA
5-Yr Chart
Click to enlarge
High Rs1,4131,285 109.9%   
Low Rs848634 133.8%   
Sales per share (Unadj.) Rs353.3189.6 186.3%  
Earnings per share (Unadj.) Rs23.4-0.2 -11,485.6%  
Cash flow per share (Unadj.) Rs41.03.8 1,066.2%  
Dividends per share (Unadj.) Rs5.000-  
Dividend yield (eoy) %0.40-  
Book value per share (Unadj.) Rs320.468.6 466.9%  
Shares outstanding (eoy) m89.3525.00 357.4%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x3.25.1 63.2%   
Avg P/E ratio x48.3-4,712.7 -1.0%  
P/CF ratio (eoy) x27.6249.6 11.0%  
Price / Book Value ratio x3.514.0 25.2%  
Dividend payout %21.40-   
Avg Mkt Cap Rs m100,98823,988 421.0%   
No. of employees `0004.71.6 300.8%   
Total wages/salary Rs m4,9881,605 310.9%   
Avg. sales/employee Rs Th6,730.03,040.2 221.4%   
Avg. wages/employee Rs Th1,063.61,029.2 103.3%   
Avg. net profit/employee Rs Th445.5-3.3 -13,645.2%   
INCOME DATA
Net Sales Rs m31,5644,740 665.9%  
Other income Rs m1,21292 1,316.2%   
Total revenues Rs m32,7764,832 678.3%   
Gross profit Rs m5,213-130 -4,016.1%  
Depreciation Rs m1,573101 1,554.2%   
Interest Rs m1,8030-   
Profit before tax Rs m3,049-139 -2,195.2%   
Minority Interest Rs m1270-   
Prior Period Items Rs m-270-   
Extraordinary Inc (Exp) Rs m-371139 -267.0%   
Tax Rs m6895 13,527.5%   
Profit after tax Rs m2,089-5 -41,049.5%  
Gross profit margin %16.5-2.7 -603.1%  
Effective tax rate %22.6-3.7 -616.2%   
Net profit margin %6.6-0.1 -6,164.2%  
BALANCE SHEET DATA
Current assets Rs m35,9492,726 1,318.6%   
Current liabilities Rs m19,4022,435 796.8%   
Net working cap to sales %52.46.1 852.7%  
Current ratio x1.91.1 165.5%  
Inventory Days Days7174 96.1%  
Debtors Days Days12741 311.1%  
Net fixed assets Rs m34,4781,035 3,330.2%   
Share capital Rs m89450 1,787.0%   
"Free" reserves Rs m22,601942 2,398.2%   
Net worth Rs m28,6321,716 1,668.5%   
Long term debt Rs m27,4550-   
Total assets Rs m76,5914,156 1,842.9%  
Interest coverage x2.7NM-  
Debt to equity ratio x1.00-  
Sales to assets ratio x0.41.1 36.1%   
Return on assets %5.1-0.1 -4,149.6%  
Return on equity %7.3-0.3 -2,460.2%  
Return on capital %8.20-  
Exports to sales %48.15.7 844.3%   
Imports to sales %14.56.5 223.8%   
Exports (fob) Rs m15,192270 5,622.6%   
Imports (cif) Rs m4,565306 1,490.2%   
Fx inflow Rs m16,612375 4,434.6%   
Fx outflow Rs m5,292470 1,125.6%   
Net fx Rs m11,320-96 -11,847.0%   
CASH FLOW
From Operations Rs m717-8 -8,846.9%  
From Investments Rs m-22,284-146 15,294.6%  
From Financial Activity Rs m29,488862 3,420.0%  
Net Cashflow Rs m8,073709 1,139.4%  

Share Holding

Indian Promoters % 27.7 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 37.8 0.3 12,600.0%  
FIIs % 8.6 15.7 54.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.9 9.1 284.6%  
Shareholders   56,241 12,856 437.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STRIDES SHASUN LTD With:   SANOFI INDIA  ABBOTT INDIA  FRESENIUS KABI ONCO.  WYETH LTD  TORRENT PHARMA  

Compare STRIDES SHASUN LTD With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades Marginally Higher; Pharma Stocks Among Top Gainers(01:30 pm)

After opening the day in green, share markets in India witnessed choppy trades and are presently trading marginally above the dotted line.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

STRIDES SHASUN LTD SHARE PRICE


Aug 22, 2017 03:08 PM

TRACK STRIDES SHASUN LTD

  • Track your investment in STRIDES SHASUN LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STRIDES SHASUN LTD

STRIDES SHASUN LTD 5-YR ANALYSIS

COMPARE STRIDES SHASUN LTD WITH

MARKET STATS